Living with a blocked blood vessel in the eye, known as a retinal vein occlusion, can threaten your sight. For many patients, managing swelling in the macula is the primary goal to keep their vision clear. A large review of data from over 2,000 patients looked at whether combining anti-VEGF drugs with corticosteroids works better than using anti-VEGF drugs alone.
The results showed that the combination therapy led to better visual acuity and thinner swelling in the macula compared to single-drug treatment. Patients receiving the combination also saw a significant drop in the number of extra injections needed over a six-month period. However, this approach comes with specific trade-offs. The study found that patients on the combined treatment had higher eye pressure and an increased risk of needing cataract surgery.
While the combination therapy offers better results for vision and fewer injections, it is not a perfect fix for everyone. Because of the risks involving eye pressure and cataracts, doctors must weigh these benefits against potential complications. The study also noted that while patients might need fewer injections, they may still require frequent monitoring to manage side effects from the steroids.
